SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- 13 January 2026 (Beijing Time), Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) announced today that the New Drug Application (NDA) for its novel, orally administered, highly selective, and potent...
Hence then, the article about abbisko therapeutics announces fda acceptance of the nda for pimicotinib for the treatment of tenosynovial giant cell tumor was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Abbisko Therapeutics Announces FDA Acceptance of the NDA for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor )
Also on site :
- FIFA’s plan to raise billions from investors is sparking a backlash—one insider says Europe is angry because it could change soccer’s balance of power
- Monroe County committees vote to accept $160,000 Operation Stonegarden border security grant despite opposition
- Doc Talk Podcast: Director Sara Dosa On Her Oscar Contender ‘Time And Water’, Elegy For Iceland’s Disappearing Ice